Barbara Dalie

Title: Barbara Dalie: Innovator in TNF-α Convertase Research

Introduction

Barbara Dalie is a prominent inventor based in Annandale, NJ (US), known for her significant contributions to the field of biochemistry and molecular biology. With a total of nine patents to her name, she has made remarkable advancements in the understanding and application of TNF-α convertases.

Latest Patents

Her latest patents focus on the isolation and application of human and bovine TNF-α convertases. These inventions provide isolated nucleic acids and recombinant vectors encoding the convertases, as well as host cells that incorporate these nucleic acids and vectors. Additionally, her work includes the development of antibodies and antigen-binding fragments that specifically target these convertases, which are crucial for treating medical conditions associated with TNF-α. Furthermore, her patents outline screening methods for identifying specific inhibitors of mammalian TNF-α convertases and for discovering nucleic acids that encode such convertases.

Career Highlights

Barbara Dalie has established herself as a key figure in her field through her innovative research and patent contributions. She is currently associated with Schering Corporation, where she continues to advance her work in biochemistry and therapeutic applications.

Collaborations

Throughout her career, Barbara has collaborated with notable colleagues, including Paul J Zavodny and Xuedong Fan, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Barbara Dalie's work in the field of TNF-α convertases exemplifies her dedication to innovation and research. Her contributions have the potential to significantly impact medical treatments and improve patient outcomes.